Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tatva Chintan Pharma Chem (NSE:TATVA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Tatva Chintan Pharma Chem Net Margin % Related Terms
Tatva Chintan Pharma Chem Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:TATVA vs LIN, SHW, ECL: Net Margin % Comparison
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem Net Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Net Margin % distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem (NSE:TATVA) has a Net Margin % of 9.57% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Tatva Chintan Pharma Chem and its competitors. This is near median its historical median of 10.48. Over the past decade, Tatva Chintan Pharma Chem's Net Margin % has ranged from 1.49 to 22.23. According to the industry distribution chart, Tatva Chintan Pharma Chem ranks #422 out of 1583 companies in the Chemicals industry, placing it in the top 26.7%.
Is Tatva Chintan Pharma Chem's Net Margin % too high?
Tatva Chintan Pharma Chem's current Net Margin % of 9.57% is near median its 10-year median of 10.48. Over the past 10 years, this metric has ranged from a low of 1.49 to a high of 22.23. The Chemicals industry median Net Margin % is 4.25. Tatva Chintan Pharma Chem's value of 9.57% is 125.2% above this industry median. Based on the distribution chart, Tatva Chintan Pharma Chem ranks #422 out of 1583 companies in the Chemicals industry, which is above the industry midpoint. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Net Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tatva Chintan Pharma Chem ranks #422 out of 1583 companies for Net Margin %. This puts Tatva Chintan Pharma Chem in the upper half of its industry. The industry median Net Margin % is 4.25. Tatva Chintan Pharma Chem's value of 9.57% is 125.2% above this benchmark. Historically, Tatva Chintan Pharma Chem's own Net Margin % has ranged from 1.49 to 22.23 over the past decade. While the company's 10-year median is 10.48 vs. the industry median of 4.25, Tatva Chintan Pharma Chem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Chemicals company?
The median Net Margin % among Chemicals companies is 4.25, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tatva Chintan Pharma Chem's current Net Margin % of 9.57% is 125.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Tatva Chintan Pharma Chem and its competitors. For the Chemicals industry, the median Net Margin % is 4.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tatva Chintan Pharma Chem's current Net Margin % is 9.57%, which is near median its own 10-year median of 10.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,514.76, compared to a current price of ₹1,717.30 — trading 13.4% above its estimated fair value. The current Net Margin % is 9.57%, which is near median its 10-year median of 10.48 and 125.2% above the Chemicals industry median of 4.25. Tatva Chintan Pharma Chem's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current Net Margin % is 9.57% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued.
The current stock price of ₹1,717.30 is trading 13.4% above its estimated GF Value™ of ₹1,514.76.
GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Overvalued.
Key valuation signals for NSE:TATVA:
Net Margin %: 9.57% (near median its 10-year median of 10.48)
GF Value™: ₹1,514.76 vs. price of ₹1,717.30 (13.4% above fair value)
Industry Position: 125.2% above the Chemicals median (#422 of 1583)
No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
82GF Score
Get the complete analysis for NSE:TATVA
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TATVA has been successfully added to your 
